The effect of riboflavin to prevent the migraine in 5-13 year-old childre
Not Applicable
- Conditions
- Migraine.Episodic and paroxysmal disorders
- Registration Number
- IRCT2013020412361N1
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
5-13 year-old migraineous children according to ICHD II criteria who have minimally two moderate to severe migraine attacks monthly.
Exclusion criteria: Epilepsy or severe neurologic disorders ; Liver, kidney, GI, metabolic or cardiovascular disorders ; Use of migraine prophylactic drugs during the last month ; Incooperation of parents or patients ; Headache attacks less than twice per month ; Tension headache ; Mild migraine headache
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of headache. Timepoint: last month of treatment. Method of measurement: interview with parents and child.;Intensity of headache. Timepoint: last month of treatment. Method of measurement: interview with parents and child.;Frequency of headache attacks. Timepoint: last month of treatment. Method of measurement: interview with parents and child.
- Secondary Outcome Measures
Name Time Method rine color change. Timepoint: during the study weekly. Method of measurement: interview with parents and children.